首页 > 市场调查报告书 > 製药

癌症

市场调查报告书

商品编码

1542588

全球光化性角化症治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Actinic Keratosis Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 124 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球光化性角化症治疗市场的需求预计将从 2023 年的 70.2 亿美元达到 2032 年近 111.7 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 5.3%。

皮肤表面出现厚厚的鳞状或硬皮斑块，显示癌前病变，称为光化性角化症。光化性角化症是常见的问题。人们的心态和生活方式正在发生变化，消费者对护肤品进行投资。这在光化性角化症治疗市场中发挥重要作用。光化性角化症的治疗过程是最低限度的干扰。治疗程序接受度的提高刺激了市场。癌症发生率的上升、慢性病盛行率的增加以及久坐的生活方式正在推动全球光化性角化病治疗产业的发展。预计在预测期内将出现良好的成长。

市场动态

全球光化性角化症治疗市场正在经历成长。推动光化性角化症治疗市场的决定因素有多种。最明显的因素之一是光化性角化病患病率的增加。适当的医疗保险和关注的可用性，以及过度阳光照射和臭氧层消耗等环境因素，归因于角化病治疗市场。另一方面，治疗的高成本和风险因素减缓了其市场成长。然而，它确实有改进和加强的潜力。

该报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。

此外，这些工具还对全球光化性角化病治疗市场中的每个应用/产品领域进行了包容性评估。

市场区隔

整个光化性角化症治疗市场已细分为治疗、药物类别、最终用途前景。该报告根据地理细分对这些子集进行了分析。这项研究将使行销人员了解情况，并有助于确定产品或服务的目标族群。

透过治疗

专题
手术
光动力疗法
按药物类别
核苷代谢抑制剂
非类固醇抗发炎药
免疫反应调节剂
光增强剂
其他的
按最终用途
医院
私人诊所
居家护理
其他的
区域分析

本节涵盖区域细分，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲光化性角化病治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区对个别应用领域的需求。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。光化性角化症治疗市场的主要参与者包括 Almirall SA、LEO Pharma A/S、Sun Pharmaceutical Industries Ltd.、诺华 AG、Galderma、Ortho Dermatologics (Bausch Health Companies Inc.) 和 Biofrontera AG。本节包括竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：光化性角化症治疗公司的竞争格局

光化性角化症治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Almirall SA

公司概况
公司收入
产品
最新动态

LEO Pharma A/S

公司概况
公司收入
产品
最新动态

Sun Pharmaceutical Industries Ltd.

公司概况
公司收入
产品
最新动态

Novartis AG

公司概况
公司收入
产品
最新动态

Galderma

公司概况
公司收入
产品
最新动态

Ortho Dermatologics (Bausch Health Companies Inc.)

公司概况
公司收入
产品
最新动态

Biofrontera AG

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11211663

The global demand for Actinic Keratosis Treatment Market is presumed to reach the market size of nearly USD 11.17 Billion by 2032 from USD 7.02 Billion in 2023 with a CAGR of 5.3% under the study period 2024 - 2032.

The presence of thick, scaly or crusty patches on the skin surface indicating premalignant condition is referred as actinic Keratosis. Actinic Keratosis is a commonly found problem. The mindset and lifestyle of people is shifting and consumers invest on skin care. This plays a major role in the actinic Keratosis treatment market. The actinic Keratosis treatment procedures are minimally obtrusive. Increase in acceptance of therapeutic procedures combust the market. Rising incidences of cancer, increasing prevalence off chronic diseases and sedentary lifestyle are driving the global actinic Keratosis treatment industry. It is predicted to have a favorable growth over the forecasted period.

Market Dynamics

The global actinic Keratosis treatment market is experiencing a growth. There are various determinants that propel the actinic Keratosis treatment market. One of the most obvious factors is the increasing prevalence of actinic Keratosis. The availability of suitable medical coverage and attention, along with environmental factors such as excessive sun exposure and depletion in the ozone layer, attribute to the Keratosis treatment market. On the other hand, the high cost and the risk factors involved with the treatment have slowed down its market growth. However, it does have the potential to improve and accentuate.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of actinic keratosis treatment.

Market Segmentation

The entire actinic keratosis treatment market has been sub-categorized into therapy, drug class, end use outlook. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Therapy

Topical
Surgery
Photodynamic Therapy
By Drug Class
Nucleoside Metabolic Inhibitors
NSAIDs
Immune Response Modifiers
Photoenhancers
Others
By End Use
Hospitals
Private Clinics
Homecare
Others
Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for actinic keratosis treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Actinic Keratosis Treatment market include Almirall S.A., LEO Pharma A/S, Sun Pharmaceutical Industries Ltd., Novartis AG, Galderma, Ortho Dermatologics (Bausch Health Companies Inc.), Biofrontera AG. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. ACTINIC KERATOSIS TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Therapy
- 3.7.2 Market Attractiveness Analysis By Drug Class
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS BY THERAPY

5.1. Overview By Therapy
5.2. Historical and Forecast Data
5.3. Analysis By Therapy
5.4. Topical Historic and Forecast Sales By Regions
5.5. Surgery Historic and Forecast Sales By Regions
5.6. Photodynamic Therapy Historic and Forecast Sales By Regions

6. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS BY DRUG CLASS

6.1. Overview By Drug Class
6.2. Historical and Forecast Data
6.3. Analysis By Drug Class
6.4. Nucleoside Metabolic Inhibitors Historic and Forecast Sales By Regions
6.5. NSAIDs Historic and Forecast Sales By Regions
6.6. Immune Response Modifiers Historic and Forecast Sales By Regions
6.7. Photoenhancers Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS BY END USE

7.1. Overview By End Use
7.2. Historical and Forecast Data
7.3. Analysis By End Use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Private Clinics Historic and Forecast Sales By Regions
7.6. Homecare Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ACTINIC KERATOSIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ACTINIC KERATOSIS TREATMENT COMPANIES

9.1. Actinic Keratosis Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF ACTINIC KERATOSIS TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Almirall S.A.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. LEO Pharma A/S
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Sun Pharmaceutical Industries Ltd.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Novartis AG
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Galderma
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Ortho Dermatologics (Bausch Health Companies Inc.)
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Biofrontera AG
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments